Satyawan Jadhav

2.1k total citations
41 papers, 1.6k citations indexed

About

Satyawan Jadhav is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Satyawan Jadhav has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 12 papers in Pharmacology. Recurrent topics in Satyawan Jadhav's work include Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (11 papers) and Lipoproteins and Cardiovascular Health (6 papers). Satyawan Jadhav is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (11 papers) and Lipoproteins and Cardiovascular Health (6 papers). Satyawan Jadhav collaborates with scholars based in United States, India and Australia. Satyawan Jadhav's co-authors include Craig W. Lindsley, P. Jeffrey Conn, Girish Kumar Jain, Carrie K. Jones, Thomas M. Bridges, Colleen M. Niswender, C. David Weaver, J. Phillip Kennedy, Usha N. Menon and Ashley E. Brady and has published in prestigious journals such as Circulation, Journal of Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Satyawan Jadhav

39 papers receiving 1.6k citations

Peers

Countries citing papers authored by Satyawan Jadhav

Since Specialization

Citations

This map shows the geographic impact of Satyawan Jadhav's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satyawan Jadhav with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satyawan Jadhav more than expected).

Fields of papers citing papers by Satyawan Jadhav

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satyawan Jadhav. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satyawan Jadhav. The network helps show where Satyawan Jadhav may publish in the future.

Co-authorship network of co-authors of Satyawan Jadhav

This figure shows the co-authorship network connecting the top 25 collaborators of Satyawan Jadhav. A scholar is included among the top collaborators of Satyawan Jadhav based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satyawan Jadhav. Satyawan Jadhav is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metformin’s protection against blood-brain barrier disruption and neuronal dysfunction under oxygen-glucose deprivation and tobacco smoke and e-vape chemical exposure 2025 ·Fluids and Barriers of the CNS ·(unknown), (unknown), Satyawan Jadhav, Yong Zhang, Thomas J. Abbruscato	0
2	Population pharmacokinetic and pharmacokinetic-pharmacodynamic modeling of bempedoic acid and low-density lipoprotein cholesterol in healthy subjects and patients with dyslipidemia 2023 ·Journal of Pharmacokinetics and Pharmacodynamics ·Satyawan Jadhav, Benny Amore, Howard N. Bockbrader, Ryan L. Crass, Sunny Chapel, William J. Sasiela, Maurice G. Emery	4
3	Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series – Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2 2018 ·Bioorganic & Medicinal Chemistry Letters ·Muthukaman Nagarajan, (unknown), (unknown), (unknown), (unknown), Mahamadhanif S. Shaikh, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abhay Kulkarni, (unknown), Satyawan Jadhav, (unknown), Girish Gudi, Neelima Khairatkar-Joshi, Laxmikant A. Gharat	5
4	Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1 2017 ·Bioorganic & Medicinal Chemistry Letters ·Muthukaman Nagarajan, (unknown), (unknown), (unknown), (unknown), Mahamadhanif S. Shaikh, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abhay Kulkarni, (unknown), Satyawan Jadhav, (unknown), Girish Gudi, Neelima Khairatkar-Joshi, Laxmikant A. Gharat	5
5	Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model 2017 ·Bioorganic & Medicinal Chemistry Letters ·Muthukaman Nagarajan, (unknown), Mahamadhanif S. Shaikh, (unknown), (unknown), (unknown), (unknown), Lakshminarayana Narayana, (unknown), (unknown), (unknown), (unknown), Abhay Kulkarni, (unknown), Satyawan Jadhav, Girish Gudi, Neelima Khairatkar-Joshi, Laxmikant A. Gharat	6
6	Tissue Distribution of a Therapeutic Monoclonal Antibody Determined by Large Pore Microdialysis 2017 ·Journal of Pharmaceutical Sciences ·Satyawan Jadhav, (unknown), (unknown), Michael B. Otteneder, W. Richter, Hartmut Derendorf	31
7	Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization 2016 ·The AAPS Journal ·Amelia N. Deitchman, (unknown), (unknown), Satyawan Jadhav, Hartmut Derendorf	12
8	Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2′,3′:3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor 2016 ·Bioorganic & Medicinal Chemistry Letters ·Muthukaman Nagarajan, (unknown), (unknown), (unknown), (unknown), (unknown), Mahamadhanif S. Shaikh, (unknown), (unknown), (unknown), Abhay Kulkarni, Satyawan Jadhav, (unknown), Girish Gudi, Neelima Khairatkar-Joshi, Laxmikant A. Gharat	8
9	Microdialysis of Large Molecules 2016 ·Journal of Pharmaceutical Sciences ·Satyawan Jadhav, (unknown), Hartmut Derendorf	30
10	Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: Part I 2014 ·Bioorganic & Medicinal Chemistry Letters ·Sanjib Das, (unknown), (unknown), Neelima Khairatkar-Joshi, Malini Bajpai, (unknown), (unknown), Girish Gudi, (unknown), (unknown), Satyawan Jadhav, Abraham Thomas	8
11	Discovery of benzo[d]imidazo[5,1-b]thiazole as a new class of phosphodiesterase 10A inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Abhisek Banerjee, Lakshminarayana Narayana, (unknown), (unknown), (unknown), Srinivas Gullapalli, Hemant Kumar, Sandeep Vasant More, Malini Bajpai, (unknown), Satyawan Jadhav, Girish Gudi, Neelima Khairatkar-Joshi, (unknown), (unknown), Laxmikant A. Gharat	23
12	Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women 2012 ·Menopause The Journal of The North American Menopause Society ·Annu Makker, Man Mohan Singh, Geetanjali Mishra, Balendra Pratap Singh, Girish Kumar Jain, Satyawan Jadhav	21
13	Allosteric Modulators of Metabotropic Glutamate Receptor 5 for Treatment of Schizophrenia 2011 ·Research Portal (Queen's University Belfast) ·Shaun R. Stauffer, Jason Manka, Richard D. Williams, (unknown), Satyawan Jadhav, (unknown), Paige N. Vinson, Colleen M. Niswender, Jerri M. Rook, Craig W. Lindsley, C. David Weaver, P. Jeffrey Conn, (unknown), Emily Days	1
14	(3-Cyano-5-fluorophenyl)biaryl Negative Allosteric Modulators of mGlu₅: Discovery of a New Tool Compound with Activity in the OSS Mouse Model of Addiction 2011 ·ACS Chemical Neuroscience ·Craig W. Lindsley, (unknown), Usha N. Menon, Satyawan Jadhav, (unknown), Carrie K. Jones, Alice L. Rodriguez, P. Jeffrey Conn, Christopher M. Olsen, Danny G. Winder, Kyle A. Emmitte	18
15	The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, N. Turle-Lorenzo, Marianne Amalric, Anna L. Blobaum, Thomas M. Bridges, Ryan D. Morrison, Satyawan Jadhav, Darren W. Engers, (unknown), (unknown), J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, P. Jeffrey Conn, Colleen M. Niswender	81
16	Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity 2010 ·Molecular Pharmacology ·Alice L. Rodriguez, Mark D. Grier, Carrie K. Jones, (unknown), (unknown), Randy L. Smith, Richard D. Williams, Ya Zhou, Joy E. Marlo, Emily Days, (unknown), Satyawan Jadhav, Usha N. Menon, Paige N. Vinson, Jerri M. Rook, Shaun R. Stauffer, Colleen M. Niswender, Craig W. Lindsley, C. David Weaver, P. Jeffrey Conn	147
17	Discovery of the First Highly M5-Preferring Muscarinic Acetylcholine Receptor Ligand, an M5 Positive Allosteric Modulator Derived from a Series of 5-Trifluoromethoxy N -Benzyl Isatins 2009 ·Journal of Medicinal Chemistry ·Thomas M. Bridges, Joy E. Marlo, Colleen M. Niswender, Carrie K. Jones, Satyawan Jadhav, Patrick R. Gentry, (unknown), C. David Weaver, P. Jeffrey Conn, Craig W. Lindsley	88
18	A Selective Allosteric Potentiator of the M₁Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning 2009 ·Journal of Neuroscience ·Jana K. Shirey, Ashley E. Brady, Paulianda J. Jones, Albert A. Davis, Thomas M. Bridges, J. Phillip Kennedy, Satyawan Jadhav, Usha N. Menon, Zixiu Xiang, (unknown), Edward P. Christian, James Doherty, Michael C. Quirk, (unknown), James J. Lah, Allan I. Levey, Michelle M. Nicolle, Craig W. Lindsley, P. Jeffrey Conn	199
19	Novel allosteric modulators of metabotropic glutamate receptors subtypes 2 and 5 for the treatment of schizophrenia 2008 ·Neuropharmacology ·Carrie K. Jones, Fangfang Xiang, Andrew K. Jones, Nellie Byun, (unknown), (unknown), Jennifer Ayala, Colleen M. Niswender, Satyawan Jadhav, Douglas J. Sheffler, Alexis S. Hammond, (unknown), A.K. Thompson, Richard D. Williams, (unknown), C. David Weaver, Craig W. Lindsley, P. Jeffrey Conn	1
20	Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Ashley E. Brady, Carrie K. Jones, Thomas M. Bridges, J. Phillip Kennedy, Analisa D. Thompson, (unknown), (unknown), Patrick R. Gentry, Huiyong Yin, Satyawan Jadhav, Jana K. Shirey, P. Jeffrey Conn, Craig W. Lindsley	162

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact